Sarolaner

Barclays on Thursday gave a Healthcare spotlight on Zoetis Inc (NYSE: ZTS) after the biotech company reported fourth quarter earnings of $0.40 per share, beating analyst estimates of $0.37 EPS. Zoetis also reported fourth quarter revenues of $1.32 billion, again beating consensus estimates of $1....